Hot Pursuit     16-Apr-24
Caplin Point rises on USFDA nod for eye drops
Caplin Point Laboratories added 1.67% to Rs 1,318.75 after its subsidiary, Caplin Steriles received final approval from the US drug regulator for its abbreviated new drug application (ANDA) Ofloxacin Ophthalmic Solution.
The approved ANDA is a generic therapeutic equivalent version of reference listed drug (RLD), Ocuflox Ophthalmic Solution of Allergan Inc.

Ofloxacin Ophthalmic Solution (eye drops) is indicated for treatment of eye infections caused during the conditions of conjunctivitis and corneal ulcers.

According to IQVIA (IMS Health), Ofloxacin Ophthalmic Solution had US sales of approximately $52 million for the 12- month period ending December 2023.

Caplin Point Laboratories is a fast-growing pharmaceutical company with a unique business model catering predominantly to emerging markets of Latin America and Africa. The company has manufacturing facilities that cater to a complete range of finished dosage forms.

The company‘s consolidated net profit jumped 30.1% to Rs 119.82 crore on 17% increase in revenue from operations to Rs 435.50 crore in Q3 FY24 over Q3 FY23.

Previous News
  Benchmarks trades with small gains; media shares in demand
 ( Market Commentary - Mid-Session 19-Aug-24   10:33 )
  Indices trade with major gains; pharma shares in demand
 ( Market Commentary - Mid-Session 07-Aug-24   14:33 )
  Caplin Point Laboratories fixes record date for final dividend
 ( Market Beat - Reports 07-Aug-24   13:17 )
  Caplin Point rallies after Q1 PAT climbs 20% YoY to Rs 125 cr
 ( Hot Pursuit - 07-Aug-24   13:23 )
  Caplin Point Laboratories announces board meeting date
 ( Corporate News - 03-Nov-23   15:56 )
  Caplin Point hits life high after Chennai unit clears Brazilian Agency’s inspection
 ( Hot Pursuit - 19-Aug-24   09:46 )
  Caplin Point Laboratories Ltd leads gainers in 'A' group
 ( Hot Pursuit - 19-Aug-24   12:00 )
  Caplin Point Laboratories fixes record date for final dividend
 ( Market Beat - Reports 05-Sep-22   12:58 )
  Caplin Point Laboratories consolidated net profit rises 29.93% in the June 2021 quarter
 ( Results - Announcements 05-Aug-21   13:50 )
  Board of Caplin Point Laboratories accepts cessation of director
 ( Corporate News - 05-Sep-22   13:21 )
  Volumes soar at Hindustan Zinc Ltd counter
 ( Hot Pursuit - 19-Aug-24   11:00 )
Other Stories
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
  GRSE bags Rs 226-cr LoA from West Bengal Govt
  04-Oct-24   14:40
  Volumes soar at Avenue Supermarts Ltd counter
  04-Oct-24   14:30
  Real Estate stocks edge lower
  04-Oct-24   14:00
  Auto stocks edge lower
  04-Oct-24   14:00
  Utilties stocks edge lower
  04-Oct-24   14:00
  HDFC Bank Ltd down for fifth straight session
  04-Oct-24   13:35
  Power Grid Corporation of India Ltd down for fifth straight session
  04-Oct-24   13:35
Back Top